Stocksigma LogoStocksigma Logo

Remus Pharmaceuticals Schedules H1 FY27 Earnings Conference Call

Remus Pharmaceuticals Limited will host an earnings conference call on 4th Nov'26 at 12:00 PM IST to discuss its unaudited standalone and consolidated

Remus Pharmaceuticals Schedules H1 FY27 Earnings Conference Call

Remus Pharmaceuticals Ltd 路 Intimation 路 29 Oct 2026, 12:39 am

Remus Pharmaceuticals Schedules H1 FY27 Earnings Conference Call Remus Pharmaceuticals Limited will host an earnings conference call on 4th Nov'26 at 12:00 PM IST to discuss its unaudited standalone and consolidated financial results for the half year ended 30th Sep'26 (H1 FY27). The management will be represented by Managing Director Arpit Shah and Chief Financial Officer Bhavik Shah. Universal dial-in access numbers include +91 22 6280 1341 and +91 22 7115 8242, with international toll-free options available. The call recording and transcript will subsequently be made available on the company's website.

Original exchange filing (PDF)

More announcements from Remus Pharmaceuticals Ltd

All Remus Pharmaceuticals Ltd announcements